F

Florida Retina Consultants | Lakeland, FL

Research site

(Unclaimed)

Location

2202 Lakeland Hills Blvd, Lakeland, Florida, United States of America

Site insights

Top conditions

Top treatments

Aflibercept

Runcaciguat

ABP 938

KSI-301

Tonabersat

YD312

Abicipar Pegol

Triamcinolone Acetonide

Bevacizumab

Pemafibrate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 24 total trials

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join...

Enrolling

Diabetic Retinopathy

Drug: BI 764524

Drug: Aflibercept (Eylea®) - US only

Fenofibrate for Prevention of DR Worsening (Protocol AF)

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 y...

Enrolling

Diabetic Retinopathy

Other: Placebo

Drug: Fenofibrate

Locations recently updated

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...

Enrolling

Wet Age-related Macular Degeneration

WetAMD

Biological: Aflibercept (EYLEA®)

Genetic: ABBV-RGX-314 Dose 2

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration (ODYSSEY)

Phase 2b, randomized, double-masked, parallel-group, active-controlled, multicenter, 36-week study designed to assess the safety and efficacy of supr...

Active, not recruiting

Neovascular Age-related Macular Degeneration

Drug: Aflibercept

Drug: CLS-AX